Daniel Lysák

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cell therapy products represent a new trend of treatment in the field of immunotherapy and regenerative medicine. Their biological nature and multistep preparation procedure require the application of complex release criteria and quality control. Microbial contamination of cell therapy products is a potential source of morbidity in recipients. The automated(More)
  • 1